• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53基因突变在具有统一可治愈阶段的食管鳞状细胞癌患者中具有预后价值。

The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.

作者信息

Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T

机构信息

Second Department of Surgery, Chiba University School of Medicine, Japan.

出版信息

Am J Surg. 1999 Jun;177(6):497-502. doi: 10.1016/s0002-9610(99)00085-9.

DOI:10.1016/s0002-9610(99)00085-9
PMID:10414702
Abstract

BACKGROUND

The p53 gene alteration is identified in approximately half of all human tumors, and is now thought to be a key gene for regulating the cell cycle through the induction of p21(WAF1/CIP1) and inducing apoptosis through some genes such as BAX. In this study, we investigated the prognostic value of p53 mutation for postoperative esophageal squamous cell carcinoma patients.

METHODS

The subjects studied were 42 esophageal squamous cell carcinoma patients who underwent esophagectomy with complete curability in our department. The cases were limited to stage II and III. DNA was extracted from paraffin-embedded tissues. A p53 gene mutation was detected by polymerase chain reaction-single strand conformation polymorphism and subsequent direct sequencing method for exons 5 to 9. The 5-year survival rate was calculated and statistically compared between the p53 mutation(+) and (-) groups by the log rank test.

RESULTS

The p53 gene mutation was identified in 14 cases (33.3%). The 5-year survival rate of the p53 mutation(-) group (n = 28) was significantly higher than the (+) group (n = 14; 51.0% versus 35.7%, P <0.05 by the log rank test). Recurrence could be identified in 10 of 14 p53 mutation(+) cases (71.4%), whereas it was found in 12 of 28 (-) cases (42.8%).

CONCLUSION

The current study indicated that p53 mutation of tumor tissues might be a prognostic factor for esophageal squamous cell carcinoma cases and one of the risk factors for its recurrence.

摘要

背景

p53基因改变在大约一半的人类肿瘤中被发现,目前被认为是通过诱导p21(WAF1/CIP1)来调节细胞周期以及通过一些基因(如BAX)诱导细胞凋亡的关键基因。在本研究中,我们调查了p53突变对术后食管鳞状细胞癌患者的预后价值。

方法

研究对象为42例在我科接受了根治性食管切除术的食管鳞状细胞癌患者。病例限于II期和III期。从石蜡包埋组织中提取DNA。通过聚合酶链反应-单链构象多态性及随后的外显子5至9直接测序法检测p53基因突变。计算5年生存率,并通过对数秩检验对p53突变(+)组和(-)组进行统计学比较。

结果

14例(33.3%)检测到p53基因突变。p53突变(-)组(n = 28)的5年生存率显著高于(+)组(n = 14;51.0%对35.7%,对数秩检验P<0.05)。14例p53突变(+)病例中有10例(71.4%)出现复发,而28例(-)病例中有12例(42.8%)出现复发。

结论

当前研究表明,肿瘤组织的p53突变可能是食管鳞状细胞癌病例的一个预后因素,也是其复发的危险因素之一。

相似文献

1
The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.p53基因突变在具有统一可治愈阶段的食管鳞状细胞癌患者中具有预后价值。
Am J Surg. 1999 Jun;177(6):497-502. doi: 10.1016/s0002-9610(99)00085-9.
2
Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.p21(WAF1)表达失调的过表达影响手术切除的食管鳞状细胞癌患者的生存。
Ann Thorac Surg. 2005 Sep;80(3):1007-16. doi: 10.1016/j.athoracsur.2005.03.050.
3
Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation.中国患者食管鳞状细胞癌中HPV感染的患病率及其与p53基因突变的关系。
Int J Cancer. 1997 Sep 17;72(6):959-64. doi: 10.1002/(sici)1097-0215(19970917)72:6<959::aid-ijc7>3.0.co;2-o.
4
Prognostic significance of the p53 mutation in esophageal cancer.
Jpn J Clin Oncol. 1996 Oct;26(5):287-92. doi: 10.1093/oxfordjournals.jjco.a023234.
5
p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.通过PCR-冷单链构象多态性分析检测食管鳞状细胞癌中的p53基因改变。
Proc Natl Sci Counc Repub China B. 1998 Jul;22(3):114-21.
6
Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.
J Gastroenterol. 2001 May;36(5):303-11. doi: 10.1007/s005350170095.
7
Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.埃及食管癌中的人乳头瘤病毒感染:与p53、p21、mdm2、C-erbB2的相关性及其对生存的影响
Pathol Int. 2005 Feb;55(2):53-62. doi: 10.1111/j.1440-1827.2005.01804.x.
8
p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.意大利早期和进展期食管鳞状细胞癌中的p53改变但无人乳头瘤病毒感染
Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):171-6.
9
Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.使用p53酵母功能分析法检测人食管鳞状细胞癌中的p53基因突变:青年组与老年组食管癌发生过程中可能存在的差异
Clin Cancer Res. 2001 Mar;7(3):600-6.
10
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.食管癌中p53蛋白积累与p53基因突变:一项与临床病理相关性的分子及免疫组织化学研究
Cancer. 1997 Feb 1;79(3):425-32. doi: 10.1002/(sici)1097-0142(19970201)79:3<425::aid-cncr1>3.0.co;2-h.

引用本文的文献

1
PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.PRIMA-1通过上调Noxa在具有TP53错义突变的食管鳞状细胞癌中诱导p53介导的细胞凋亡。
Cancer Sci. 2018 Feb;109(2):412-421. doi: 10.1111/cas.13454. Epub 2017 Dec 28.
2
Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.局部晚期食管鳞状细胞癌新辅助放化疗的现状与展望
Surg Today. 2016 Mar;46(3):261-7. doi: 10.1007/s00595-015-1144-0. Epub 2015 Mar 5.
3
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
食管癌生存、治疗反应及分期的体细胞和生殖系DNA序列生物标志物的系统评价与荟萃分析。
Ann Oncol. 2015 Apr;26(4):624-644. doi: 10.1093/annonc/mdu449. Epub 2014 Sep 11.
4
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.术前C反应蛋白作为食管癌鳞状细胞癌和腺癌围手术期病程及长期预后参数的意义
World J Gastroenterol. 2006 Jun 21;12(23):3746-50. doi: 10.3748/wjg.v12.i23.3746.
5
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.用于耐放化疗的晚期食管鳞状细胞癌的I/II期腺病毒p53基因治疗
Cancer Sci. 2006 Jun;97(6):554-61. doi: 10.1111/j.1349-7006.2006.00206.x.
6
p53 gene therapy for esophageal cancer.用于食管癌的p53基因治疗
J Gastroenterol. 2002 Nov;37 Suppl 14:87-91. doi: 10.1007/BF03326422.
7
Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma.血管生成因子的表达可预测食管鳞状细胞癌对放化疗的反应及预后。
Br J Cancer. 2002 Feb 12;86(4):552-7. doi: 10.1038/sj.bjc.6600129.
8
p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.与食管癌相关的鳞状上皮发育异常中p53的表达:场癌化的证据
Br J Cancer. 2000 Oct;83(8):1033-8. doi: 10.1054/bjoc.2000.1443.